NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II |
Nimotuzumab cold kit for the immunodiagnosis of solid tumors |
Nimotuzumab for the treatment of high grade of malignancy tumors |
Nimotuzumab in COVID-19 |
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS) |
Nimotuzumab in tumors of head and neck .Phase IV |
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV |
Nimotuzumab- Head and neck cancer |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
NUTRIRES2 |
Obex® - Overweight and Obese - Adults - Phase III |
Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2 |
OLIVO Study |
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II |
Oncoxin-Viusid-Advanced or metastatic ovarian epithelial cancer-Adult women-Phase II |
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II |
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II |
Oropharyngeal sanitization with electrolyzed superoxidation solution with neutral pH to prevent COVID-19 |
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |